Accellacare of Duly

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Bladder cancer2 trials
• Lung cancer1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Recruiting3 trials
• Not yet recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Astellas Pharma Global Development, Inc.1 trial
• Pfizer1 trial

Running trials

• Recruiting

  A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder

  NCT07475806· Phase 2· Astellas Pharma Global Development, Inc.· Source

  Contact: Astellas Pharma Global Development, Inc.

• Recruiting

  A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  NCT07174336· Phase 3· Eli Lilly and Company· Source

  Contact: Daniel Frank (principal investigator)

• Recruiting

  A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  NCT07218380· Phase 3· Eli Lilly and Company· Source

  Contact: Brian Myre (principal investigator)

• Recruiting

  A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  NCT07144280· Phase 3· Pfizer· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer2 recruiting
• Lung cancer1 recruiting
• Metastatic breast cancer1 recruiting